[1] 乔宇琪,张敏红,吴建新,等.关于PBL医学教育的若干认识[J].医学与哲学(人文社会医学版),2009,30(1):75-76.
[2] Sockol L E, Epperson C N, Barber J P. Preventing postpartum depression: a meta-analytic review [J].Clin Psychol Rev,2013,33(8):1205-1217.
[3] Blume J, Douglas S D, Evans D L. Immune suppression and immune activation in depression [J]. Brain Behavior Immun,2011,25(2): 221?229.
[4] Rowe H, Baker T, Hale T W. Maternal medication, drug use, and breast feeding [J]. Pediatr Clin North Am,2013, 60(1): 275-294.
[5] Hantsoo L, Wardo ,Brien D, Czarkowski K A, et al. A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression [J].Psychopharmacology,2014, 231(5):939-948.
[6] Naughton M,Mulrooney J B,Leonard B E.A review of the role of serotonin receptors in psychiatric disorders [J]. Hum Psychopharmacol, 2000,15(6):397-415.
[7] Ruhe H G,Mason N S,Schene A H. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies[J].Mol Psychiatry, 2007,12(4):331-359.
[8] Zhang L M, Zhao N, Guo W Z, et al.Antidepressant-like and anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa) [J].Neuropharmacology,2014,81(6): 116-125.
[9] Keenan P, Yaldoo D, Stress M, et al. Explicitmemory in pregnant women[J].Am J Obstet Gynecol,1998,179(3):731-737.
[10] O,Hara M W, Sclechte J A, Lewis D A, Varner M W. Controlled prospective study of postpartum mood disorders: psychological, environmental, and hormonal variables [J].J Abnorm Psychol,1991,100(1):63-73.
[11] Guintivano J,Arad M,Gould T D,et al. Antenatal prediction of postpartum depression with blood DNA methylation biomarkers[J]. Mol Psychiatry,2013,19(5): 560-567.
[12] Galea L A M,Wide J K, Barr A M, et al. Estradiol alleviates depressive-like symptoms in a novel animal model of postpartum depression[J].Behavioural Brain Res,2001,122(1):1-9.
[13] Groer M W,Morgan K. Immune,health and endocrine characteristics of depressed postpartum mothers[J].Psychoneuroendocrinology,2007,32(2):133-139.
[14] Delpech J C, Madore C, Nadjar A, et al. Microglia in neuronal plasticity: influence of stress [J]. Neuropharmacology, 2015,96 (PtA):19-28.
[15] Corwin E J,Johnston N,Pugh L. Symptoms of postpartum depression associated with elevated levels of interleukin-1beta during the first month postpartum [J].Biol Res Nursing,2008,10(2):128-133.
[16] Ramirez K, Sheridan J F. Antidepressant imipramine diminishes stress-induced inflammation in the periphery and central nervous system and related anxiety- and depressive-like behaviors [J]. Brain Behavior Immunity,2016,57(1): 293-303.
[17] Bobo W V,Yawn B P.Concise review for physicians and other clinicians: postpartum depression[J].Mayo Clin Proceedings,2014,89(6): 835-844.
[18] Hardwick M,Fertikh D,Culty M,et al.Peripheral-type benzodiazepine receptor ( PBR ) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression,nuclear localization,and PBR-mediated cell prolif-eration and nuclear transport of cholesterol[J].Cancer Res,1999,59( 4): 831-842.
[19] Akwa Y, Purdy R H , Koob G F, et al .The amygdala medi-ates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat[J].Behavior Brain Res,1999, 106(1-2):119-125.
[20] Kita A, Kohayakawa H,Kinoshita T,et al. Antianxiety and antidepressant-like effects of AC-5216, a novel mitochondrial benzodiazepine receptor ligand [J] .Br J Pharmacol,2004,142(7):1059-1072.
[23] Costa B,Da Pozzo E,Martini C. Translocator protein as a promising target for novel anxiolytics[J]. Curr Topics Med Chem,2012,12(4):270-285.
[24] Rupprecht R ,Rammes G, Eser D, et al .Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects[J].Science, 325(5939):490-493.